Synteract

Synteract

An innovative CRO providing full-service, Phase I-IV services to biopharma companies.
  • Edit
DateInvestorsAmountRound

N/A

Growth Equity VC

N/A

Growth Equity VC
N/A

$3.0m

Growth Equity VC

N/A

Acquisition
Total FundingAUD4.6m

Recent News about Synteract

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.